NCT01768312View on ClinicalTrials.gov

Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group

PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

August 23, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Dry Eye Syndromes
Interventions
DRUG

Cyclosporine ophthalmic solution

1 drop twice/day for 12 weeks to both eyes

Trial Locations (1)

137-701

The catholic university of Korea seoul st. Mary's hospital, Seoul

All Listed Sponsors
lead

Hanlim Pharm. Co., Ltd.

INDUSTRY

NCT01768312 - Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group | Biotech Hunter | Biotech Hunter